A Study to Measure Whether PF-06480605 is Safe and Effective in the Treatment of Moderate to Severe Ulcerative Colitis

A Phase 2a, Multicenter, Single Arm, Open-Label, Two-Stage, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
PF-06480605
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7541002
Open Plain Language Summary Result:Click here